MIRA INFORM REPORT

 

 

Report Date :

19.04.2014              

 

IDENTIFICATION DETAILS

 

Name :

AZELIS ESPAÑA SA

 

 

Registered Office :

Pl. De La Pau, S/N Wtc Almeda Park. Cornella De Llobregat, 08940

 

 

Country :

Spain

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

1998

 

 

Com. Reg. No.:

A61744033

 

 

Legal Form :

Public Subsidiary

 

 

Line of Business :

Wholesale trade in chemicals for the pharmaceutical, veterinary, cosmetic, food and fine chemical industries

 

 

No. of Employees

72

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

Spain

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

SPAIN ECONOMIC OVERVIEW

 

Spain experienced a prolonged recession in the wake of the global financial crisis. GDP contracted by 3.7% in 2009, ending a 16-year growth trend, and continued contracting through most of 2013. Economic growth resumed in late 2013, albeit only modestly, as credit contraction in the private sector, fiscal austerity, and high unemployment continued to weigh on domestic consumption and investment. Exports, however, have been resilient throughout the economic downturn, partially offsetting declines in domestic consumption and helped to bring Spain's current account into surplus in 2013 for the first time since 1986. The unemployment rate rose from a low of about 8% in 2007 to more than 26% in 2013, straining Spain's public finances as spending on social benefits increased while tax revenues fell. Spain’s budget deficit peaked at 11.4% of GDP in 2009. Spain gradually reduced the deficit to just under 7% of GDP in 2013, slightly above the 6.5% target negotiated between Spain and the EU. Public debt has increased substantially – from 60.1% of GDP in 2010 to 93.4% in 2013. Rising labor productivity, moderating labor costs, and lower inflation have helped to improve foreign investor interest in the economy and to reduce government borrowing costs. The government's ongoing efforts to implement reforms - labor, pension, health, tax, and education - are aimed at supporting investor sentiment. The government also has shored up struggling banks exposed to Spain's depressed domestic construction and real estate sectors by successfully completing an EU-funded restructuring and recapitalization program in December 2013

 

Source : CIA

 

 

 


Company name and address

AZELIS ESPAÑA SA

 

Pl. De La Pau, S/N Wtc Almeda Park.

Cornella De Llobregat, 08940

Spain

 

Tel:

+(34) 934745126

Fax:

+(34) 933392162

 

www.impexquimica.com

 

Employees:

72

Company Type:

Public Subsidiary

Corporate Family:

7 Companies

Ultimate Parent:

Azelis Holding Sa

Incorporation Date:

1998

Auditor:

Deloitte S.L.

 

Fiscal Year End:

20-Aug-2013

Reporting Currency:

Euro

Annual Sales:

100.8  1

Net Income:

0.0

Total Assets:

40.6

                                         

 

Business Description

 

 

Wholesale trade in chemicals for the pharmaceutical, veterinary, cosmetic, food and fine chemical industries

 

Industry

             

 

Industry

Health and Personal Care Wholesale

ANZSIC 2006:

3720 - Pharmaceutical and Toiletry Goods Wholesaling

ISIC Rev 4:

4649 - Wholesale of other household goods

NACE Rev 2:

4646 - Wholesale of pharmaceutical goods

NAICS 2012:

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

UK SIC 2007:

4646 - Wholesale of pharmaceutical goods

US SIC 1987:

5122 - Drugs, Drug Proprietaries, and Druggists' Sundries

 

 

Key Executives   

   

 

Name

Title

Antonio Juan Barios Boncompte

Combined Chief Executive Officer, Member Of The Board, Secretary

Muller Hans Joaquim

Combined Chief Executive Officer, Member Of The Board

Francisco Aguilera Armengol

Presidente

Laia Creus

Director de Exportación

Estivaliz Letamendia

Director de Recursos Humanos

>>View 8 Executives & 5 Board Members

 

Registered No.(ESP): A61744033

1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7663997


2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.7494969

 

 

Corporate Overview

 

Location
Pl. De La Pau, S/N Wtc Almeda Park.
Cornella De Llobregat, 08940
Spain

 

Tel:

+(34) 934745126

Fax:

+(34) 933392162

 

www.impexquimica.com

Sales EUR(mil):

77.2

Assets EUR(mil):

30.5

Employees:

72

Fiscal Year End:

20-Aug-2013

 

Industry:

Personal and Household Products

Incorporation Date:

1998

Company Type:

Public Subsidiary

Quoted Status:

Not Quoted

Previous Name:

Impex Química, S.A.

Registered No.(ESP):

A61744033

 

Chief Executive Officer, Member Of The Board, President:

Javier Perez Garcia

 

 

Industry Codes

 

ANZSIC 2006 Codes:

3720

-

Pharmaceutical and Toiletry Goods Wholesaling

3323

-

Industrial and Agricultural Chemical Product Wholesaling

 

ISIC Rev 4 Codes:

4649

-

Wholesale of other household goods

4669

-

Wholesale of waste and scrap and other products n.e.c.

 

NACE Rev 2 Codes:

4646

-

Wholesale of pharmaceutical goods

4675

-

Wholesale of chemical products

 

NAICS 2012 Codes:

424210

-

Drugs and Druggists' Sundries Merchant Wholesalers

424690

-

Other Chemical and Allied Products Merchant Wholesalers

 

US SIC 1987:

5122

-

Drugs, Drug Proprietaries, and Druggists' Sundries

5169

-

Chemicals and Allied Products, Not Elsewhere Classified

 

UK SIC 2007:

4646

-

Wholesale of pharmaceutical goods

4675

-

Wholesale of chemical products

 

 

Business Description

Agents involved in the sale of a variety of goods

More Business Descriptions

Wholesale trade in chemicals for the pharmaceutical, veterinary, cosmetic, food and fine chemical industries

All Other Chemical Product and Preparation Manufacturing

 

 

Financial Data

Financials in:

EUR(mil)

Revenue:

77.2

Net Income:

0.0

Assets:

30.5

Current Assets:

20.1

Fixed Assets:

10.4

Long Term Debt:

1.6

Total Liabilities:

30.5

Issued Capital:

0.6

Net Worth:

13.8

Date of Financial Data:

20-Aug-2013

1 Year Growth

-13.2%

NA

NA

 

 

Key Corporate Relationships

Auditor:

Deloitte S.L.

Bank:

Banco Bilbao Vizcaya Argentaria, S.A.

Auditor:

Deloitte S.L.

 

 

 

Corporate Structure News

 

 

 

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

Azelis Holding Sa

Parent

Azelis Sa

Subsidiary

Luxembourg

Luxembourg

Holding Companies

10.9

Azelis Italia SRL

Subsidiary

Trezzano Sul Naviglio, Milano

Italy

Chemical Wholesale

115.2

75

Azelis España Sa

Subsidiary

Cornella De Llobregat, Barcelona

Spain

Health and Personal Care Wholesale

100.8

72

Azelis Italia Logistica SRL

Subsidiary

Trezzano Sul Naviglio, Milano

Italy

Internet and Web Services

1.9

6

Azelis Tr Kimya Endustrisi Urunleri Ithalat Ihracat Ticaret Ve Sanayi A S

Subsidiary

Istanbul (Europe)

Turkey

Chemical Wholesale

22.3

28

Azelis Deutschland Holding GmbH

Subsidiary

Sankt Augustin, Nordrhein-Westfalen

Germany

Holding Companies

1

 

 

Executives Report

 

 

 

Board of Directors

 

Name

Title

Function

 

Francisco Aguilera Armengol

Presidente

Chairman

 

Antonio Juan Barios Boncompte

Combined Chief Executive Officer, Member Of The Board, Secretary

Director/Board Member

 

Muller Hans Joaquim

Combined Chief Executive Officer, Member Of The Board

Director/Board Member

 

Hollenhorst Martin Wilhelm

Combined Chief Executive Officer, Member Of The Board

Director/Board Member

 

Javier Perez Garcia

Chief Executive Officer, Member Of The Board, President

Director/Board Member

 

 

Executives

 

Name

Title

Function

 

Antonio Juan Barios Boncompte

Combined Chief Executive Officer, Member Of The Board, Secretary

Chief Executive Officer

 

Muller Hans Joaquim

Combined Chief Executive Officer, Member Of The Board

Chief Executive Officer

 

Hollenhorst Martin Wilhelm

Combined Chief Executive Officer, Member Of The Board

Chief Executive Officer

 

Javier Perez Garcia

Chief Executive Officer, Member Of The Board, President

Chief Executive Officer

 

Francisco Aguilera Armengol

Presidente

President

 

Estivaliz Letamendia

Director de Recursos Humanos

Human Resources Executive

 

Laia Creus

Director de Exportación

Sales Executive

 

Corporation Sl Seward

Single Partner

Partner

 

 
Annual Profit & Loss

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

Period Length

12 Months

12 Months

12 Months

Filed Currency

EUR

EUR

EUR

Exchange Rate (Period Average)

0.778237

0.71919

0.755078

Consolidated

No

No

No

 

 

 

 

Charges

101.4

124.6

117.5

    Supplies

85.7

106.6

100.9

        Goods Consumption

85.7

106.6

100.9

    Staff Costs

7.4

7.0

7.2

        Wages and Salaries

6.5

5.9

5.8

        Social Security Costs

1.0

1.1

1.4

    Depreciation

0.1

0.2

0.2

    Allowance for Trade Operations

0.1

0.1

0.0

        Stock Provision Variation

-0.1

0.0

0.0

        Losses from Unrecovered Receivables

0.2

0.1

0.0

    Other Operating Charges

7.4

9.6

8.4

        External Services

7.4

9.6

8.4

        Taxes

0.0

0.0

0.0

Operating Benefits

-

1.8

1.6

    Financials and Similar Charges

0.6

0.7

0.4

        Due to Liabilities With Group Companies

0.0

0.0

0.0

        Due to Other Liabilities

0.5

0.6

0.4

    Exchange Losses

0.1

0.1

-

Profit From Ordinary Activities

-

1.3

1.3

    Extraordinary Expenses

-

0.0

-

Extraordinary Profit

0.2

-

0.0

Profit Before Taxes

-

1.2

1.3

    Corporation Tax

-0.1

0.4

0.4

Financial Year Result (Profit)

-

0.9

0.9

Income

101.2

125.4

118.4

    Net Total Sales

99.3

123.7

116.9

        Sales

99.4

123.9

117.1

        Sales Refunds

-0.2

-0.2

-0.2

    Miscellaneous Operating Income

1.6

1.5

1.3

        Auxiliary Income From Current Management

1.6

1.5

1.3

        Grants

0.0

0.0

0.0

Operating Losses

0.0

-

-

    Income From Equity Investment

0.2

0.2

0.1

        In Group Companies

0.2

0.2

0.1

        Third Parties

-

0.0

0.0

    Gains from Exchange Rate

-

-

0.1

Negative Financial Results

0.5

0.5

0.2

Ordinary Activities' Losses

0.5

-

-

    Profit on Disposal of Assets

0.0

0.0

0.0

    Extraordinary Income

0.2

-

0.0

Negative Extraordinary Results

-

0.0

-

Losses Before Taxes

0.3

-

-

Financial Year Result (Losses)

0.2

-

-

 

 

Annual Balance Sheet

Financials in: USD (mil)

 

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

Filed Currency

EUR

EUR

EUR

Exchange Rate

0.7566

0.770327

0.745406

Consolidated

No

No

No

 

 

 

 

        Concessions, Patents, Trademarks

0.0

0.0

-

        Software

0.2

0.2

0.3

    Total Intangible Fixed Assets

0.2

0.2

0.3

        Technical Installations and Machinery

0.0

0.0

0.0

        Other Installations, Tools, and Furniture

0.1

0.1

0.1

        Other Tangible Assets

0.1

0.2

0.2

    Total Tangible Fixed Assets

0.2

0.3

0.4

        Receivables from Group Companies

13.3

12.4

6.8

        Long-Term Guarantees and Deposits

0.1

0.1

0.1

    Financial Investments

13.3

12.4

6.9

Total Fixed Assets

13.7

12.9

7.6

        Goods for Resale

8.9

10.6

13.9

        Payments on Account

0.0

0.0

0.2

    Total Stocks

8.9

10.6

14.0

        Trade Debtors

13.7

19.1

25.3

        Receivables, Group Companies

0.9

2.9

0.3

        Other Debtors

0.2

0.2

0.3

        Public Bodies

0.3

0.2

0.4

    Total Debtors

15.1

22.3

26.3

    Cash

2.6

0.9

3.1

    Prepayments and Accrued Income

0.0

0.0

0.0

Total Current Assets

26.6

33.8

43.4

Total Assets

40.2

46.8

51.0

        Legal Reserve

0.2

0.2

0.2

        Miscellaneous Reserves

5.7

4.7

3.8

        Capital Adjustment to Euros

0.0

0.0

0.0

    Total Reserves

5.8

4.8

4.0

    Profit or Loss for the Financial Year

-0.2

0.8

1.0

Total Equity

18.2

18.0

17.7

        Provisions for Pension Fund

0.3

0.3

0.3

Total Provisions for Liabilities and Charges

0.3

0.3

0.3

        Amounts Owed to Group Companies

2.1

2.0

1.8

    Total Debts with Group or Affiliated Companies

2.1

2.0

1.8

        Long-Term Payables to Public Bodies

0.0

0.0

-

    Total Other Creditors

0.0

0.0

-

Total Long Term Liabilities

2.1

2.0

1.8

        Loans and Other Liabilities

3.4

6.0

6.8

    Total Amounts Owed to Credit Institutions

3.4

6.0

6.8

        Amounts Owed to Group Companies

0.5

3.3

1.7

    Total Short-Term Amounts Owed to Group and Associa

0.5

3.3

1.7

        Amounts Owed for Purchases of Goods or Services

14.3

15.9

21.3

    Total Trade Creditors

14.3

15.9

21.3

        Public Bodies

0.5

0.4

0.3

        Wages and Salaries Payable

1.0

0.9

1.1

    Total Other Creditors

1.4

1.3

1.4

Total Short Term Creditors

19.6

26.5

31.2

Total Liabilities and Equity

40.2

46.8

51.0

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.38

UK Pound

1

Rs.101.63

Euro

1

Rs.83.57

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

NIS

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.